Tom Seijkens
The Netherlands Cancer Institute(NL)
Publications by Year
Research Areas
Atherosclerosis and Cardiovascular Diseases, Cell Adhesion Molecules Research, Cancer Immunotherapy and Biomarkers, Immune cells in cancer, Chemokine receptors and signaling
Most-Cited Works
- → Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis(2010)293 cited
- → Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile(2010)241 cited
- → Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis(2018)190 cited
- → Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions(2014)176 cited
- → Immune Checkpoint Inhibitor Therapy Aggravates T Cell–Driven Plaque Inflammation in Atherosclerosis(2020)138 cited
- → Plasmacytoid Dendritic Cells Protect Against Atherosclerosis by Tuning T-Cell Proliferation and Activity(2011)128 cited
- → Efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates(2018)125 cited
- → Blocking CD40-TRAF6 signaling is a therapeutic target in obesity-associated insulin resistance(2014)124 cited
- → Hypercholesterolemia‐induced priming of hematopoietic stem and progenitor cells aggravates atherosclerosis(2014)110 cited
- → Immune Cell Crosstalk in Obesity: A Key Role for Costimulation?(2014)109 cited